Cobrotoxin could be an effective therapeutic for COVID-19

• 作者: Fang Lin Paul F.Reid Zheng-hong Qin
• 来源期刊: 中国药理学报（英文版）
• 年，卷（期）: 2020,（9）
• 所属期刊栏目: Correspondence
• 页码范围: 1258-1260
• 页数: 3页
• 语种: 英文

摘要

Dear Editor, A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), was declared a pandemic in 2020.It is generally agreed that the inflammatory cytokine storm, which causes systemic inflammation leading to multiple organ failures, is an important pathogenic mechanism in severe cases of COVlD-19 [1].Based on previous studies of cobra venom by the authors and other independent researchers, cobrotoxin, a short-chain α-neurotoxin from Naja naja atra venom (NNAV), could be an alternative therapy for COVID-19.